Milsap R L, Plaisance K I, Jusko W J
Clin Pharmacol Ther. 1984 Dec;36(6):824-31. doi: 10.1038/clpt.1984.263.
Obesity is accompanied by altered secretion and disposition of sex and glucocorticoid hormones, including cortisol, and also confounds parameter normalization and drug dosage selection relative to body weight. Prednisolone disposition was assessed in eight obese and four normal male subjects after a dose of 33 mg iv. Steroid concentrations were determined by HPLC. Kinetics were related to ideal body weight (IBW) and total body weight (TBW). Uncorrected steady-state volume of distribution (Vss) of total prednisolone was 20% greater in obese subjects (36.7 and 44.1 l). This effect could be described by the relationship: Vss = 0.54 IBW + 0.09(TBW-IBW), with a distribution coefficient of 0.09 reflecting limited prednisolone uptake by fat. Protein binding parameters and albumin and transcortin concentrations were similar between groups. Uncorrected total and free prednisolone clearances (Cl) were increased in obesity (11.1 and 8.3 l/hr total; 65.4 and 46.5 l/hr free). Free prednisolone Cl correlated strongly (r = 0.80) with degree of obesity expressed as TBW/IBW. In the obese, endogenous cortisol concentrations were initially higher before exogenous steroid dosing, were suppressed at an identical rate, and returned to baseline more slowly than in normal subjects. The apparent hypersensitivity of the adrenal gland offsets the increased Cl of free prednisolone in obesity, indicating that weight-proportional dosage adjustments of this steroid in obesity should reflect TBW.
肥胖与包括皮质醇在内的性激素和糖皮质激素的分泌及分布改变有关,并且在根据体重进行参数标准化和药物剂量选择方面也存在混淆。对8名肥胖男性和4名正常男性受试者静脉注射33 mg剂量的泼尼松龙后,评估其处置情况。通过高效液相色谱法测定类固醇浓度。动力学与理想体重(IBW)和总体重(TBW)相关。肥胖受试者中未校正的泼尼松龙总稳态分布容积(Vss)比正常受试者大20%(分别为36.7升和44.1升)。这种效应可用以下关系描述:Vss = 0.54 IBW + 0.09(TBW - IBW),分布系数0.09反映了泼尼松龙在脂肪中的摄取受限。两组之间的蛋白质结合参数以及白蛋白和转皮质素浓度相似。肥胖者中未校正的泼尼松龙总清除率和游离清除率(Cl)均增加(总清除率分别为11.1升/小时和8.3升/小时;游离清除率分别为65.4升/小时和46.5升/小时)。游离泼尼松龙Cl与以TBW/IBW表示的肥胖程度密切相关(r = 0.80)。在肥胖者中,外源性类固醇给药前内源性皮质醇浓度最初较高,以相同速率被抑制,且恢复到基线的速度比正常受试者慢。肾上腺的明显超敏反应抵消了肥胖者中游离泼尼松龙Cl的增加,这表明肥胖者中该类固醇按体重比例进行剂量调整时应反映TBW。